Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor

Sensors and Actuators, B: Chemical

Volumn 146, Issue 1, 2010, Pages 226-230

  Gohring, John T ^a   Dale, Paul S ^a   Fan, Xudong ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; HER2; Label free; Optical biosensor; Ring resonator

Indexed keywords

BREAST CANCER; CELLULAR DOMAIN; DISEASE PROGRESSION; HUMAN SERUM; LABEL-FREE APPROACH; LABEL-FREE DETECTION; LABEL-FREE OPTICAL BIOSENSORS; OPTICAL RING RESONATORS; OPTO-FLUIDIC RING RESONATOR; RING RESONATOR; SENSING TECHNOLOGY;

BIOMARKERS; BODY FLUIDS; LABELS; OPTICAL RESONATORS; PROTEINS;

BIOSENSORS;

EID: 77949913944     PISSN: 09254005     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.snb.2010.01.067     Document Type: Article

References (35)

1. Cheng H.D., Shan J., Ju W., Guo Y., and Zhang L. Automated breast cancer detection and classification using ultrasound images: a survey. Pattern Recogn. 43 (2009) 299-317
2. M. E. Lippman, Harrison's Principles of Internal Medicine, 2008.
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer Statistics 2006. CA Cancer J. Clin. 56 (2006) 106-130
4. Kearney A.J., and Murray M. Breast cancer screening recommendations: is mammography the only answer?. J. Midwife. Women Health 54 (2008) 393-400
5. Gullick W.J. Update on HER-2 as a target for cancer therapy: alternative strategies for targeting the epidermal growth factor system in cancer. Breast Cancer Res. 3 (2001) 390-394
6. Riccio G., Esposito G., Leoncini E., Contu R., Condorelli G., Chiariello M., Laccetti P., Hrelia S., D'Alessio G., and De Lorenzo C. Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB 23 (2009) 3171-3178
7. Cho H., Mason K., Raymer K.X., Stanley A.M., Gabelli S.B., Denney D.W., and Leahy D.J. Structure of the extracellular region of HER2 alone and in complex with the herceptin fab. Nature 421 (2003) 756-760
8. Mass R.D., Press M.F., Anderson S., Cobleigh M.A., Vogel C.L., Dybdal N., Leiberman G., and Slamon D.J. Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin. Breast Cancer 6 (2005) 240-246
9. Ramos-Vara J.A. Technical aspects of immunohistochemistry. Vet. Pathol. 42 (2005) 405-426
10. Sieben V.J., Debes M., Pilarski P.M., Kaigala G.V., Pilarski L.M., and Backhouse C.J. FISH and chips: chromosomal analysis on microfluidic platforms. IET Nanobiotechnol. 1 (2007) 27-35
11. Mukundan H., Zubicek J.Z., Holt A., Shively J.E., Martinez J.S., Grace K., Grace W.K., and Swanson B.I. Planar optical waveguide-based biosensor for the quantitative detection of tumor markers. Sens. Actuators B: Chem. 138 (2009) 453-460
12. Chan D.W., Beveridge A., Bhargava A., Wilcox P.M., Kennedy M.J., and Schwartz M.K. Breast cancer marker CA549. A multicenter study. Am. J. Clin. Pathol. 101 (1994) 465-470
13. Capobianco J.A., Shih W.Y., Yuan Q., Adams G.P., and Shih W. Label-free, all-electrical, in situ human epidermal growth receptor 2 detection. Rev. Sci. Instrum. 79 (2008) 076101
14. Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde A., Flemming T., Eiermann W., Wolter J., Pegram M., Baselga J., and Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344 (2001) 783-792
15. Tse C., Brault D., Gligorow J., Antoine M., Neumannm R., Lotz J., and Capeau J. Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients. Clin. Chem. 51 (2005) 1093-1101
16. Fan X., White I.M., Shopova S.I., Zhu H., Suter J.D., and Sun Y. Sensitive optical biosensors for unlabeled targets: a review. Anal. Chim. Acta 620 (2008) 8-26
17. Qavi A.J., Washburn A.L., Byeon J.Y., and Bailey R.C. Label-free technologies for quantitative multiparameter biological analysis. Anal. Bioanal. Chem. 394 (2009) 121-135
18. Fan X. Advanced photonic structures for biological and chemical detection. Integrated Analytical Systems (2009), Springer, New York
19. Wang X., Zhao M., and Nolte D.D. Prostate-specific antigen immunoassays on the BioCD. Anal. Bioanal. Chem. 393 (2009) 1151-1156
20. Ymeti A., Subramaniam V., Beumer T.A.M., and Kanger J.S. An ultrasensitive young interferometer handheld sensor for rapid virus detection. Exp. Rev. Med. Dev. 4 (2007) 447-454
21. Densmore A., Vachon M., Xu D.-X., Janz S., Ma R., Li Y.-H., Lopinski G., Delâge A., Lapointe J., Luebbert C.C., Liu Q.Y., Cheben P., and Schmid J.H. Silicon photonic wire biosensor array for multiplexed real-time and label-free molecular detection. Opt. Lett. 34 (2009) 3598-3600
22. Chung J.W., Bernhardt R., and Pyun J.C. Additive assay of cancer marker CA 19-9 by SPR biosensor. Sens. Actuators B: Chem. 118 (2006) 28-32
23. Vaisocherova H., Faca V.M., Taylor A.D., Hanash S., and Jiang S. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera. Biosens. Bioelectron. 15 (2009) 2143-2148
24. Vollmer F., Braun D., Libchaber A., Khoshsima M., Teraoka I., and Arnold S. Protein detection by optical shift of a resonant microcavity. Appl. Phys. Lett. 80 (2002) 4057-4059
25. Washburn A.L., Gunn L.C., and Bailey R.C. Label-free quantitation of a cancer biomarker in complex media using silicon photonic microring resonators. Anal. Chem. 81 (2009) 9499-9506
26. White I.M., Oveys H., and Fan X. Liquid-core optical ring-resonator sensors. Opt. Lett. 31 (2006) 1319-1321
27. Zhu H., White I.M., Suter J.D., Zourob M., and Fan X. Opto-fluidic micro-ring resonator for sensitive label-free viral detection. Analyst 133 (2008) 356-360
28. Suter J.D., White I.M., Zhu H., Shi H., Caldwell C.W., and Fan X. Label-free quantitative DNA detection using the liquid core optical ring resonator. Biosens. Bioelectron. 23 (2007) 1003-1009
29. White I.M., Gohring J., and Fan X. SERS-based detection in an optofluidic ring resonator platform. Opt. Express. 15 (2007) 17433-17442
30. J. T. Gohring, X. Fan, "Detection of CD4+ and CD8+T-lymphocytes with the optofluidic ring resonator (OFRR) biosensor" Proc SPIE 7322, 73220D (2009).
31. Zhu H., Dale P.S., Caldwell C.W., and Fan X. Rapid, label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with opto-fluidic ring resonator sensors. Anal. Chem. 81 (2009) 9858-9865
32. Zhu H., White I.M., Suter J.D., Dale P.S., and Fan X. Analysis of biomolecule detection with opto-fluidic ring resonator sensors. Opt. Express. 15 (2007) 9139-9146
33. Langmuir I. The constitution and fundamental properties of solids and liquids. Part i. Solids. J. Am. Chem. Soc. 38 (1916) 2221-2295
34. LeVan M.D., and Vermeulen T. Binary Langmuir and Freundlich isotherms for ideal absorbed solutions. J. Phys. Chem. 85 (1981) 3247-3250
35. Suter J.D., Sun Y., Howard D.J., Viator J., and Fan X. PDMS embedded opto-fluidic microring resonator lasers. Opt. Express. 16 (2008) 10248-10253